Impairment of pulmonary function as a main risk factor for ineffective endobronchial valve placement in patients with chronic cavitary tuberculosis

M. Chushkin (Moscow, Russian Federation), L. Popova (Moscow, Russian Federation), E. Shergina (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Shabalina (Moscow, Russian Federation), T. Bagdasaryan (Moscow, Russian Federation), N. Chernykh (Moscow, Russian Federation), E. Krasnikova (Moscow, Russian Federation), O. Gordeeva (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation)

Source: Virtual Congress 2020 – Conventional bronchoscopy
Session: Conventional bronchoscopy
Session type: E-poster session
Number: 2840
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Chushkin (Moscow, Russian Federation), L. Popova (Moscow, Russian Federation), E. Shergina (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Shabalina (Moscow, Russian Federation), T. Bagdasaryan (Moscow, Russian Federation), N. Chernykh (Moscow, Russian Federation), E. Krasnikova (Moscow, Russian Federation), O. Gordeeva (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation). Impairment of pulmonary function as a main risk factor for ineffective endobronchial valve placement in patients with chronic cavitary tuberculosis. 2840

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary function before and early after endobronchial valve placement in patients with chronic cavitary tuberculosis
Source: International Congress 2019 – Interventional pulmonology: re-sculpting the airway
Year: 2019

Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Blocking of bronchoscopic endobronchial valve in the complex surgical treatment of patients with pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Pulmonary tuberculosis in elderly patients – particular endobronchial aspects
Source: Annual Congress 2008 - Difficult tuberculosis cases
Year: 2008

Presence of bronchopulmonary shunting is an independent risk factor for recurrence of hemoptysis following bronchial artery embolization in younger patients with bronchiectasis: a long-term outcome
Source: International Congress 2019 – Highlights in lung function and chronic cough
Year: 2019

Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteria.
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019


Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism
Source: Eur Respir J, 49 (5) 1601980; 10.1183/13993003.01980-2016
Year: 2017




Endobronchial valve application as a method to stop lung hemorrhage in patients with lung tuberculosis
Source: Annual Congress 2008 - Surgical treatment of lung tuberculosis
Year: 2008

Charectristics of pulmonary cavitary lesion in patients with pulmonary TB
Source: Eur Respir J 2004; 24: Suppl. 48, 284s
Year: 2004

A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Impact of endobronchial valves on patient reported outcomes in severe emphysema
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006

Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2004; 24: Suppl. 48, 199s
Year: 2004

Characteristics of pulmonary cavitary lesions in patients with pulmonary TB
Source: Eur Respir J 2003; 22: Suppl. 45, 247s
Year: 2003

Endobronchial valve treatment of terminal emphysema patients with high heterogeneity score
Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy
Year: 2010


Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Source: Eur Respir J 2013; 41: 302-308
Year: 2013



A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation
Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018
Year: 2019



Endobronchial valve placement impact on breathing pattern during exercise in patients with severe emphysema
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019




Implementation of the autoangiotransplant for post-resection bronchial fistulae prevention among patients with pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 424s
Year: 2005